Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00485225 | Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain | PHASE2 | COMPLETED | 77 | — | — | Jun 1, 2007 | Jul 1, 2008 | Feb 23, 2012 | 1 | United States |
| Arm | Type | Description |
|---|---|---|
| Transdermal patch (EN3270) - Titration 1 | EXPERIMENTAL | - |
| Transdermal patch (EN3270) - Titration 2 | EXPERIMENTAL | - |
| Transdermal patch (EN3270) - Titration 3 | EXPERIMENTAL | - |
| Transdermal patch (EN3270) - Titration 4 | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| EN3270 | DRUG | Transdermal Therapeutic System |
Inclusion Criteria: * Opioid experienced * Hx (min 3 months) of moderate to severe pain of non-malignant that is well controlled with current pain therapy * On a stable dose of opioid medication for greater than or equal to 14 days * Have an adequate personal support system including a co-habitant ...